 Connection
Joshua Solomon to Idiopathic Pulmonary Fibrosis
This is a "connection" page, showing publications Joshua Solomon has written about Idiopathic Pulmonary Fibrosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.531 |
|
|
|
-
Solomon JJ, Swigris JJ, Demoruelle MK. Response. Chest. 2020 10; 158(4):1778-1779.
Score: 0.383
-
Solomon JJ, Matson S, Kelmenson LB, Chung JH, Hobbs SB, Rosas IO, Dellaripa PF, Doyle TJ, Poli S, Esposito AJ, Visser A, Marin AI, Amigues I, Fernández Pérez ER, Brown KK, Mahler M, Heinz D, Cool C, Deane KD, Swigris JJ, Demoruelle MK. IgA Antibodies Directed Against Citrullinated Protein Antigens Are Elevated in Patients With Idiopathic Pulmonary Fibrosis. Chest. 2020 06; 157(6):1513-1521.
Score: 0.363
-
Yunt ZX, Chung JH, Hobbs S, Fernandez-Perez ER, Olson AL, Huie TJ, Keith RC, Janssen WJ, Goldstein BL, Lynch DA, Brown KK, Swigris JJ, Solomon JJ. High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival. Respir Med. 2017 05; 126:100-104.
Score: 0.300
-
Solomon JJ, Chung JH, Cosgrove GP, Demoruelle MK, Fernandez-Perez ER, Fischer A, Frankel SK, Hobbs SB, Huie TJ, Ketzer J, Mannina A, Olson AL, Russell G, Tsuchiya Y, Yunt ZX, Zelarney PT, Brown KK, Swigris JJ. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2016 Feb; 47(2):588-96.
Score: 0.273
-
Huie TJ, Solomon JJ. Emphysema and pulmonary fibrosis: coincidence or conspiracy? Respirology. 2013 Nov; 18(8):1163-4.
Score: 0.237
-
Peljto AL, Furusawa H, Puthenvedu D, Lee JS, Steele MP, Brancato J, Cardwell J, Blumhagen RZ, de Andrade J, Bendstrup E, Blackwell TS, Bonella F, Borie R, Braybrooke R, Brown KK, Carbone RG, Christie JD, Costabel U, Crestani B, Davidsen JR, Dieude P, Donnelly SC, Egan J, Eickelberg O, Fernández Pérez ER, Fiddler CA, Foster EE, Gibson KF, Gudmundsson G, Guthridge JM, Henry MT, Hirani N, Jenkins RG, Kass DJ, Keane MP, Kokturk N, Kropski JA, Lederer D, Leone PM, Linderholm AL, Maher TM, Mathai SK, McCarthy C, McElroy AN, Mogulkoc N, Molina-Molina M, Molyneaux PL, Montesi SB, Nathan SD, Noth I, Olaniyi JA, Oldham JM, O'Reilly KMA, Palmisciano AJ, Pardo A, Parfrey H, Planas-Cerezales L, Poletti V, Porteous MK, Puppo F, Richeldi L, Rojas M, Salinas M, Schluger N, Selman M, Shea BS, Sterclova M, Solomon JJ, Tomassetti S, Vasakova MK, Zhang Y, Corte TJ, Dickinson JL, Glaspole I, Moodley YP, Prele CMA, Ryerson CJ, Wolters PJ, Jinno M, Miyata Y, Akagawa S, Narumoto O, Kita T, Shibayama T, Li T, Owan I, Wakamatsu K, Arai T, Hirose M, Kim DS, Ohta K, Ohta S, Park JS, Park MS, Yang IV, Fingerlin TE, Miyazaki Y, Okamoto T, Inoue Y, Song JW, Schwartz DA. Idiopathic pulmonary fibrosis risk loci in East Asian populations mirror those of European populations. Am J Respir Crit Care Med. 2026 07 01; 212(7):1522-1532.
Score: 0.143
-
Kam MLW, Tjong ELH, Chaudhary S, Koelsch TL, Pryor JB, Koslow M, Mohning MP, Solomon JJ, Huie TJ, Swigris JJ, Fernández Pérez ER. Development and validation of a clinical, CT, genomic classifier and BAL scoring system for diagnosing idiopathic pulmonary fibrosis. Eur Respir J. 2025 Mar; 65(3).
Score: 0.131
-
Leavy OC, Kawano-Dourado L, Stewart ID, Quint JK, Solomon JJ, Borie R, Crestani B, Wain LV, Jenkins G, Dieudé P, Minelli C. Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study. Thorax. 2024 05 20; 79(6):538-544.
Score: 0.123
-
Fernández Pérez ER, Crooks JL, Lynch DA, Humphries SM, Koelsch TL, Swigris JJ, Solomon JJ, Mohning MP, Groshong SD, Fier K. Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety. Thorax. 2023 11; 78(11):1097-1104.
Score: 0.114
-
Chaudhary S, Weigt SS, Ribeiro Neto ML, Benn BS, Pugashetti JV, Keith R, Chand A, Oh S, Kheir F, Ramalingam V, Solomon JJ, Harper R, Lasky JA, Oldham JM. Interstitial lung disease progression after genomic usual interstitial pneumonia testing. Eur Respir J. 2023 04; 61(4).
Score: 0.114
-
Wilson TM, Solomon JJ, Humphries SM, Swigris JJ, Ahmed F, Wang H, Darrah E, Demoruelle MK. Serum antibodies to peptidylarginine deiminase-4 in rheumatoid arthritis associated-interstitial lung disease are associated with decreased lung fibrosis and improved survival. Am J Med Sci. 2023 06; 365(6):480-487.
Score: 0.113
-
Juge PA, Solomon JJ, van Moorsel CHM, Garofoli R, Lee JS, Louis-Sydney F, Rojas-Serrano J, González-Pérez MI, Mejia M, Buendia-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou KM, Sidiropoulos P, Trachalaki A, van der Vis JJ, Jamnitski A, Grutters JC, Kannengiesser C, Borie R, Kawano-Dourado L, Wemeau-Stervinou L, Flipo RM, Nunes H, Uzunhan Y, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Richez C, Schaeverbeke T, Doyle T, Wolters PJ, Debray MP, Boileau C, Porcher R, Schwartz DA, Crestani B, Dieudé P. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression. Semin Arthritis Rheum. 2021 10; 51(5):996-1004.
Score: 0.101
-
Strand MJ, Sprunger D, Cosgrove GP, Fernandez-Perez ER, Frankel SK, Huie TJ, Olson AL, Solomon J, Brown KK, Swigris JJ. Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia. Chest. 2014 Sep; 146(3):775-785.
Score: 0.063
-
Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, Brown KK. Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death. Respir Med. 2012 Apr; 106(4):588-93.
Score: 0.052
-
Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, Tsuchiya N, Rojas-Serrano J, González-Pérez MI, Mejía M, Buendía-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou K, van Moorsel CHM, van der Vis J, de Man YA, Grutters JC, Wang Y, Borie R, Wemeau-Stervinou L, Wallaert B, Flipo RM, Nunes H, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Marchand-Adam S, Frazier A, Richette P, Allanore Y, Sibilia J, Dromer C, Richez C, Schaeverbeke T, Lioté H, Thabut G, Nathan N, Amselem S, Soubrier M, Cottin V, Clément A, Deane K, Walts AD, Fingerlin T, Fischer A, Ryu JH, Matteson EL, Niewold TB, Assayag D, Gross A, Wolters P, Schwarz MI, Holers M, Solomon JJ, Doyle T, Rosas IO, Blauwendraat C, Nalls MA, Debray MP, Boileau C, Crestani B, Schwartz DA, Dieudé P. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease. N Engl J Med. 2018 12 06; 379(23):2209-2219.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|